News

Only 1 in 13 everyday patients could have participated in a pivotal international clinical trial looking at the use of catheter ablation to treat atrial fibrillation (AFib) among people with heart failure. However, new Mayo Clinic research...

ORLANDO, Fla., March 5, 2020 – Today, following recent reports from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), HIMSS announced it is clearly necessary to cancel the 2020 HIMSS Global...

Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular patients transitioning from the hospital-to-home, announced that it had raised $145.6 million...

Get ready for the latest practice-changing research in heart rhythm disorders presented at EHRA 2020, a scientific congress of the European Society of Cardiology (ESC). The annual congress of the European Heart Rhythm Association (EHRA), a...

Johnson & Johnson announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline Study. The study is designed to explore if the Heartline Study app on iPhone...

physIQ, Inc. and the U.S. Department of Veteran’s Affairs (VA) published the results of a breakthrough study aimed at validating the ability to detect the onset of heart failure exacerbation using wearable sensors and machine learning-based...

AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, announced approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS), to launch KardiaMobile in Mexico....

Abbott announced it has received CE Mark for the new Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, bringing the most advanced heart rhythm management capabilities...

iSchemaView, also known as RAPID, the worldwide leader in advanced imaging for stroke, announced the company is now RapidAI. In 2018, co-founder Dr. Greg Albers presented groundbreaking findings at the International Stroke Conference (ISC)...

Acutus Medical announced FDA clearance and CE Mark of SuperMap — a revolutionary addition to its AcQMap 3D Imaging and Mapping System. SuperMap is a high-fidelity, high-resolution mapping algorithm for both stable and transient arrhythmias....